Skip to content

Neutral Aurobindo Pharma; target of Rs 910: Motilal Oswal

Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 910 in its research report dated August 14, 2023.

Read More

​ Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 910 in its research report dated August 14, 2023. Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 910 in its research report dated August 14, 2023.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish